Evidence map›Paper›PMID 41091150›Full record

ArticleHNO2025

[Benign parotid tumors : Surgery and management of perioperative complications].

Mika R Gehrking, Konstantinos Mantsopoulos, Michael Koch, Sarina K Müller, Matti Sievert

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in HNO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mika R GehrkingHals-Nasen-Ohrenklinik, Kopf- und Halschirurgie, Universitätskliniken Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 1, 91054, Erlangen, Deutschland.
Konstantinos MantsopoulosHals-Nasen-Ohrenklinik, Kopf- und Halschirurgie, Universitätskliniken Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 1, 91054, Erlangen, Deutschland.
Michael KochHals-Nasen-Ohrenklinik, Kopf- und Halschirurgie, Universitätskliniken Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 1, 91054, Erlangen, Deutschland.
Sarina K MüllerHals-Nasen-Ohrenklinik, Kopf- und Halschirurgie, Universitätskliniken Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 1, 91054, Erlangen, Deutschland.
Matti SievertHals-Nasen-Ohrenklinik, Kopf- und Halschirurgie, Universitätskliniken Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 1, 91054, Erlangen, Deutschland. matti.sievert@uk-erlangen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumors of the parotid gland are rare and predominantly benign. The surgical management is challenging due to the close anatomical relationship to the facial nerve. Pleomorphic adenoma and cystadenolymphoma are among the most frequently occurring lesions. The surgical approach depends on the location, size and suspected diagnosis of the lesion. While radical surgical techniques were favored in the past, current practice emphasizes reducing surgical morbidity through less invasive resection methods. In this context, extracapsular dissection offers functional advantages over more extensive resections, with similarly low recurrence rates. Complications such as facial nerve palsy, salivary fistulas and Frey's syndrome occur less frequently with milder severity and are generally well-treatable, for example, with botulinum toxin. In selected cases, such as confirmed bilateral cystadenolymphoma, a conservative wait-and-scan approach may be considered as an alternative to surgery. The goal remains the complete resection of the lesion with maximum preservation of function.

Indexed as

Otorhinolaryngologic Surgical ProceduresParotid NeoplasmsPostoperative ComplicationsEvidence-Based MedicineHumansTreatment OutcomeBotulinum toxinCystadenolymphomaExtracapsular dissectionParotid glandPleomorphic adenoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.